AUS
NZ
UK
CA
USA
IND
_01_16_2025_20_57_21_272844.jpg)
Highlights
- Johnson & Johnson share price down 12% in the last 90 days.
- Earnings per share has dropped by 3.3% annually over the past three years.
- Total shareholder return for the last three years stands at -5.1%, considering dividends.
Johnson & Johnson has faced a significant decline in stock price recently, leaving investors with questions about its trajectory. Despite a history of steady performance, the company's stock has dropped sharply, reflecting broader market trends and internal challenges. Exploring the reasons behind this decline, particularly in terms of earnings per share and shareholder returns, is crucial for understanding its ongoing performance in the NYSE Healthcare Stocks sector.
Decoding the Factors Behind Johnson & Johnson’s Stock Price Drop
Johnson & Johnson (NYSE:JNJ) has experienced significant challenges over the past few years, with a 12% decrease in its share price in the last 90 days alone. This marks a notable divergence from the broader market's performance, where the market average returned around 32% over the same period. Such a decline raises questions about the factors influencing the company's stock and its direction.
Analyzing the Impact of Declining Earnings Per Share on Stock Performance
The decline in Johnson & Johnson’s stock price is not entirely disconnected from its earnings per share (EPS). Over the past three years, the company’s EPS has dropped by an average of 3.3% annually, contributing to market sentiment turning negative. This underperformance in earnings seems to have led to a market correction in its stock price, with the share price drop slightly steeper than the EPS decline.
The Impact of Dividends on Total Shareholder Return
When considering the total shareholder return (TSR), Johnson & Johnson's performance is slightly more favorable. While its share price return in the last three years stands at a negative 5%, the TSR, which accounts for dividends and any other forms of shareholder value, stands at -5.1%. The company's dividends, though not enough to offset the decline in stock price, have provided a partial buffer to shareholders.
Contrasting Short-Term and Long-Term Performance Trends
Looking at a longer timeframe, shareholders may find some comfort in Johnson & Johnson’s performance over a five-year period, where it achieved an average return of 2% annually. This return contrasts with its performance in the short-term, especially when compared to the 27% market gain in the last year.
Identifying the Potential Reasons for the Stock Price Decline
The market's performance relative to the company's earnings suggests that Johnson & Johnson may have been overvalued in the past. While its dividends have provided some compensation to shareholders, the continued decline in stock price may reflect changing market expectations and perhaps a reassessment of the company’s long-term growth potential.
Johnson & Johnson’s recent stock performance presents an interesting case for investors tracking its evolution. While short-term declines have been evident, the company’s long-term trajectory, including its steady dividend payouts, offers a different narrative. The continued performance of its core business and market conditions will be crucial factors in determining whether this downward trend will persist or if a recovery could be on the horizon.
